Filing Flows

Filing Flows › Twist Bioscience (TWST) › Who owns the stock

Who owns Twist Bioscience (TWST) stock

338 funds reported Twist Bioscience (TWST) shares in their latest 13F filings, worth $7.8B in all. The largest holder is BlackRock ($600M). Last quarter 169 funds added to their stakes and 123 cut them.

Largest holders of TWST (13F)Largest holders of TWST (13F)BlackRock$600MArtisan Partners Limited Partners…$494MFMR LLC$484MARK Investment Management LLC$468MPrice T Rowe Associates$374MState Street$333MVanguard Portfolio Management LLC$291MVanguard Capital Management LLC$278MEdgePoint Investment Group$259MWilliam Blair Investment Manageme…$224M

Largest holders (13F)

FundSharesValueChangeQuarter
BlackRock5,833,891$600Mincrease2026-06-30
Artisan Partners Limited Partnership4,802,017$494Mdecrease2026-06-30
FMR LLC4,703,044$484Mincrease2026-06-30
ARK Investment Management LLC4,549,803$468Mdecrease2026-06-30
Price T Rowe Associates3,634,652$374Mincrease2026-06-30
State Street3,232,532$333Mdecrease2026-06-30
Vanguard Portfolio Management LLC2,824,989$291Mincrease2026-06-30
Vanguard Capital Management LLC2,699,280$278Mincrease2026-06-30
EdgePoint Investment Group2,521,635$259Mdecrease2026-06-30
William Blair Investment Management, LLC2,174,594$224Mdecrease2026-06-30
Invesco1,928,229$198Mdecrease2026-06-30
Vanguard Group5,776,198$183Mincrease2025-12-31
Geode Capital Management, LLC1,619,361$167Mincrease2026-06-30
Goldman Sachs Group1,408,418$145Mdecrease2026-06-30
Thrivent Financial for Lutherans638,303$123Mdecrease2026-09-30

Twist Bioscience's latest quarter

Twist Bioscience, Q3 FY26: revenue $118M (+23% year over year), operating margin -30.6%, net loss $35.1M, operating cash flow $1.1M. The chart follows the revenue to costs, profit and cash.

Questions

Who owns the most TWST stock?

By the latest 13F filings: BlackRock ($600M); Artisan Partners Limited Partnership ($494M); FMR LLC ($484M); ARK Investment Management LLC ($468M); Price T Rowe Associates ($374M).

What is the short interest in TWST?

10,207,499 shares were sold short at the 2026-10-15 settlement, -3.4% of the float.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.